An Injection Leading to Oesophageal Perforation: A Rare Case of Contained Boerhaave's Syndrome Following Unsupervised GLP-1/GIP Receptor Agonist Dose Escalation. [PDF]
CureusSyed NS +3 more
europepmc +1 more source
Decreased risk of post-thyroidectomy hypocalcemia with history of GLP-1RA use. [PDF]
J Endocr SocAyo-Ajibola O +6 more
europepmc +1 more source
Glucagon-like peptide-1 and dual/triple receptor agonists in the treatment of metabolic dysfunction-associated steatotic liver disease: advances in mechanistic research. [PDF]
Front Med (Lausanne)Lu X, Yang L.
europepmc +1 more source
Lithium toxicity following a change from semaglutide to tirzepatide for weight loss management. [PDF]
Ment Health ClinBurson JR, Leung JG.
europepmc +1 more source
GLP-2 and GIP acutely increase superior mesenteric artery blood flow in male rats, and the effect is independent of nitric oxide and vasoactive intestinal peptide. [PDF]
Physiol RepGalsgaard KD +5 more
europepmc +1 more source
Current Insights and Future Directions on the Role of GLP-1 Receptor Agonists in Chronic Kidney Disease. [PDF]
Int J Nephrol Renovasc DisRajan K +3 more
europepmc +1 more source
Design and biological evaluation of triagonist GLP-1R/GCGR/GIPR peptides as potential therapeutic agents for diabetes and obesity. [PDF]
RSC Med ChemKalinowska I +12 more
europepmc +1 more source
Guts, Glucose, and Gallbladders: The Protective Role of GLP-1/GIP Receptor Agonists Against Biliary Complications in Patients with Type 2 Diabetes and Inflammatory Bowel Disease. [PDF]
J Clin MedKazi MAI, Singh S, Haq N.
europepmc +1 more source
Xenin-Derived Peptides: Multifaceted Regulators and Therapeutic Innovations in Metabolic Diseases. [PDF]
Drug Des Devel TherGong B +7 more
europepmc +1 more source